Novo Nordisk A/S

NONOF | OTC

Price Alert Chart Builder DCF Calculator

$39.01

-$0.91 (-2.28%)

Sep 22, 2026, 11:13 AM ET · Market open

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

-2.28%

(1D)

Rating

Updated: Sep 17, 2026

71.5

Fundamentals Excellent

Market Sentiment Neutral

Moat Wide

Full Analysis

Key Statistics

Market Data

Market Cap $173.23B

1D Range

39.01 40.03

52W Range

34 64.75

Valuation (TTM)

PE 11

PB 6.69

EV/EBITDA 7.21

Valuation (NTM)

Forward PE 12.09

Forward PEG -4.95

Price Target N/A

Cash Flow

FCF Yield 5.3%

SBC Adj. FCF Yield 5.3%

SBC Impact N/A

Margins

Gross Margin 80.7%

Operating Margin 45.8%

FCF Margin 19.9%

Growth (CAGR)

Revenue 3Y | 5Y 25.6% | 19.8%

Dil EPS 3Y | 5Y 15.8% | 7.3%

FCF 3Y | 5Y 2.4% | 5.4%

Returns

ROA 19.6%

ROE 59.1%

ROIC 29.7%

Financial Health

Net Debt

kr80.33B ($12.69B)

Current Ratio 0.87

Interest Coverage 86.86

Dividends

Div Yield 4.50%

Payout Ratio 7.2%

FCF Payout Ratio 81.8%

All Key Statistics

Loading financial charts...

Profile

A detailed description of the company is not yet available.

Sector n/a

Industry n/a

Employees n/a

IPO Date n/a

Website n/a

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 4, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞